Photodynamic therapy for cutaneous squamous cell carcinoma in situ: Impact of anatomic location, tumor diameter, and incubation time on effectiveness
- PMID: 31712171
- DOI: 10.1016/j.jaad.2019.10.079
Photodynamic therapy for cutaneous squamous cell carcinoma in situ: Impact of anatomic location, tumor diameter, and incubation time on effectiveness
Abstract
Background: Photodynamic therapy (PDT) has been reported as a treatment for cutaneous squamous cell carcinoma in situ (SCCis), but only limited data are available on the effectiveness of PDT with aminolevulinic acid (ALA-PDT).
Objective: To review the outcomes of SCCis treated with ALA-PDT and examine factors associated with response.
Methods: A retrospective review identified 58 patients with 68 primary SCCis lesions treated with ALA-PDT and blue light illumination. Patient demographics, lesion features, treatment details, clinical response, and subsequent recurrence were extracted from medical record reviews.
Results: On completion of PDT the initial complete response rate was 77.9% and was not associated with the number of PDT treatments. On multivariate analysis factors associated with response were location on the face, tumor diameter <2 cm, and longer ALA incubation time. Lesions treated with a maximum incubation time of <3 hours had a 53.3% response compared with 84.9% for longer incubation. Subsequent recurrence of SCCis was noted in 7 of 53 cases (13.2%) at a median time of 11.7 months.
Limitations: This was a retrospective study performed at a single institution without systematic follow-up.
Conclusions: ALA-PDT may be an effective treatment for selected cases of SCCis. Effectiveness is impacted by anatomic location, tumor diameter, and ALA incubation time.
Keywords: Bowen disease; aminolevulinic acid; humans; photodynamic therapy; retrospective studies; skin neoplasms; squamous cell carcinoma in situ; treatment outcome.
Copyright © 2019 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Fractionated 5-aminolevulinic acid photodynamic therapy after partial debulking versus surgical excision for nodular basal cell carcinoma: a randomized controlled trial with at least 5-year follow-up.J Am Acad Dermatol. 2013 Aug;69(2):280-7. doi: 10.1016/j.jaad.2013.02.014. Epub 2013 Apr 6. J Am Acad Dermatol. 2013. PMID: 23566914 Clinical Trial.
-
Two-fold illumination in topical 5-aminolevulinic acid (ALA)-mediated photodynamic therapy (PDT) for superficial basal cell carcinoma (sBCC): A retrospective case series and cohort study.J Am Acad Dermatol. 2016 May;74(5):899-906. doi: 10.1016/j.jaad.2015.12.009. Epub 2016 Jan 13. J Am Acad Dermatol. 2016. PMID: 26774689
-
Photodynamic therapy utilizing 10% ALA nano-emulsion gel and red-light for the treatment of squamous cell carcinoma in-situ on the trunk and extremities: Pilot study and literature update.Photodiagnosis Photodyn Ther. 2021 Sep;35:102358. doi: 10.1016/j.pdpdt.2021.102358. Epub 2021 May 29. Photodiagnosis Photodyn Ther. 2021. PMID: 34062304
-
5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges.Cancer. 1997 Jun 15;79(12):2282-308. doi: 10.1002/(sici)1097-0142(19970615)79:12<2282::aid-cncr2>3.0.co;2-o. Cancer. 1997. PMID: 9191516 Review.
-
Aminolevulinic acid photodynamic therapy for skin cancers.Dermatol Clin. 2007 Jan;25(1):5-14. doi: 10.1016/j.det.2006.09.005. Dermatol Clin. 2007. PMID: 17126737 Review.
Cited by
-
Photodynamic Therapy for the Treatment of Bowen's Disease: A Review on Efficacy, Non-Invasive Treatment Monitoring, Tolerability, and Cosmetic Outcome.Biomedicines. 2024 Apr 3;12(4):795. doi: 10.3390/biomedicines12040795. Biomedicines. 2024. PMID: 38672152 Free PMC article. Review.
-
Skin cancer: understanding the journey of transformation from conventional to advanced treatment approaches.Mol Cancer. 2023 Oct 6;22(1):168. doi: 10.1186/s12943-023-01854-3. Mol Cancer. 2023. PMID: 37803407 Free PMC article. Review.
-
Photodynamic Therapy with 5-aminolevulinic Acid 10% Gel and Red Light for the Treatment of Actinic Keratosis, Nonmelanoma Skin Cancers, and Acne: Current Evidence and Best Practices.J Clin Aesthet Dermatol. 2021 Oct;14(10):E53-E65. J Clin Aesthet Dermatol. 2021. PMID: 34976292 Free PMC article. Review.
-
Non-Surgical Treatments for Keratinocyte Carcinomas.Adv Ther. 2021 Dec;38(12):5635-5648. doi: 10.1007/s12325-021-01916-2. Epub 2021 Oct 15. Adv Ther. 2021. PMID: 34652721 Review.
-
Treatment of Non-melanoma Skin Cancers in the Absence of Mohs Micrographic Surgery.Plast Reconstr Surg Glob Open. 2020 Dec 22;8(12):e3300. doi: 10.1097/GOX.0000000000003300. eCollection 2020 Dec. Plast Reconstr Surg Glob Open. 2020. PMID: 33425610 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical